About Us

Airshield® offers proven technology to protect against virus transmission at face-to-face interactions such as medical appointments, meetings and residential care home visits. Conceived, designed and manufactured in the UK, Airshield has undergone comprehensive testing by Nottingham Trent University which showed that Airshield removes 99% of virus particles.

Airshield's management team possesses a wealth of innovation, engineering, business management and healthcare experience.

Managing Director and Airshield's inventor Nigel Shepherd first started experimenting with ways to prevent the transmission of the virus in the air by capturing the aerosols through an air intake in 2020 and has been working on ever improving prototypes since. With a strong engineering and management background, Nigel has always applied validated engineering principles to achieve high quality and long-lasting value and this remains his ethos in the development and commercialisation of Airshield.

Director Jeremy Cummin has been involved in healthcare systems for some 40 years with several start-ups and disposals to his credit. He has consulted to major companies in the healthcare and pharmaceutical industries and has acted for several central government departments. 

His experience is varied and includes a medical software business specialising in oncology and palliative care, an early-stage health informatics consultancy and an initiative bringing together digital health stakeholders to focus on collaborative volume business development. 
Jeremy is a Member of the Royal Society of Medicine

Professor Philippe Wilson is the Honorary Chief Scientific Officer to Airshield. He is a Professor of Human and Animal Medicine at Nottingham Trent University (NTU), and the Chief Scientific Officer and Director of the Primary Care Clinical Trials Unit of Willows Health under NHS Leicestgershire. He also leads the commercial research portfolio withing the Medical Technologies Innovation Facility at NTU. He is a Fellow of the Royal Society of Medicine, the Linnean Society of London, and was elected to the Royal Society of Medicine, Comparative Medicine Council, in 2022.

Philippe is appointed to the Committee on the Toxicity of Chemicals in Food, Consumer Products and the Environment at Public Health England and the Food Standards Agency, and the UK Genetics of Livestock and Equines within the Department of Food, Environment and Rural Affaris in UK Government.

He has received numerous international awards in recognition of his multidisciplinary approach to medical science, including being named by the prestigious Forbes Magazine in their 30under30 listing for Science and Healthcare in 2018, awared the Royal Society of Chemistry Joseph Black Medal for his research in analytical chemistry in 2019, and was named as one of the top 118 young chemists in the world by IUPAC in their 2019 Periodic Table of Younger Chemists, being named as the element Krypton. He is the author of more than 50 articles, book chapters and conference proceedings.

Airshield Limited owns the patented technology (UK patent GB 2597968) that makes Airshield unique. The product name Airshield® has been registered as a trademark in respect of classes 11 and 20 under UK00003594231 with effect from 11/02/21.